Shares of Viking Therapeutics VKTX have surged 63.7% in the year so far against the industry’s 12.0% fall. The upside can be attributed to the successful development of its pipeline candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback